Abstract
Anti-Mullerian hormone (AMH), a member of the transforming growth factor-β family, is produced in small amounts by ovarian granulosa cells after birth until menopause, and then becomes undetectable. AMH levels during the reproductive years are representative of the ovarian reserve and are useful to help determine egg recovery potential for ART. Whereas, AMH levels can reflect egg quantity, said levels have not been well correlated with pregnancy outcomes following IVF-ET. Therefore, the study objective characterized pregnancy outcomes by AMH levels in patients undergoing ART for infertility.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
